Auxiliary role for D-alanylated wall teichoic acid in Toll-like receptor 2-mediated survival of Staphylococcus aureus in macrophages

Immunology

Volumn 129, Issue 2, 2010, Pages 268-277

  Shiratsuchi, Akiko ^a   Shimizu, Kaori ^a   Watanabe, Ikuko ^a   Hashimoto, Yumi ^a   Kurokawa, Kenji ^b,c   Razanajatovo, Iony M ^b   Park, Keun H ^c   Park, Hae K ^c   Lee, Bok L ^c   Sekimizu, Kazuhisa ^b   Nakanishi, Yoshinobu ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c Pusan National University   (South Korea)

Author keywords

Bacterial infection; Macrophages; Phagocytosis; Teichoic acids; Toll like receptor

Indexed keywords

DEXTRO ALANINE; STRESS ACTIVATED PROTEIN KINASE; SUPEROXIDE; TEICHOIC ACID; TOLL LIKE RECEPTOR 2;

ANIMAL CELL; ARTICLE; BACTERIAL CELL WALL; BACTERIAL GENE; BACTERIUM MUTANT; DLTA GENE; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; STAPHYLOCOCCUS AUREUS; TAGO GENE;

ANIMALS; BACTERIAL PROTEINS; BACTERIOLYSIS; CARRIER PROTEINS; CELL LINE; CELL WALL; ENZYME ACTIVATION; GENETIC COMPLEMENTATION TEST; LIPOPOLYSACCHARIDES; MACROPHAGES; MAP KINASE KINASE 4; MICE; MUTAGENESIS, SITE-DIRECTED; MUTATION; PHAGOCYTOSIS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SUPEROXIDES; TEICHOIC ACIDS; TOLL-LIKE RECEPTOR 2;

EID: 73949156430     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2009.03168.x     Document Type: Article

References (45)

1. Rosenberver CM, Finlay BB. Phagocyte sabotage: disruption of macrophage signaling by bacterial pathogens. Nat Rev Mol Cell Biol 2003 4 : 385 396.
2. Coombes BK, Valdez Y, Finlay BB. Evasive maneuvers by secreted bacterial proteins to avoid innate immune responses. Curr Biol 2004 14 : R856 67.
3. Bhavsar AP, Guttman JA, Finlay BB. Manipulation of host-cell pathways by bacterial pathogens. Nature 2007 449 : 827 834.
4. Sansonetti PJ, Di Santo JP. Debugging how bacteria manipulate the immune response. Immunity 2007 26 : 149 161.
5. Nizet V. Understanding how leading bacterial pathogens subvert innate immunity to reveal novel therapeutic targets. J Allergy Clin Immunol 2007 120 : 13 22.
6. Ernst JD. Bacterial inhibition of phagocytosis. Cell Microbiol 2000 2 : 379 386.
7. Dunn WA Jr., Dorn BR, Progulske-Fox A. Trafficking of bacterial pathogens to autophagosomes. In : Klionsky DJ, ed. Autophagy. Austin : Landes Biosciences, 2003 : 233 240 chapter 19.
8. Levine B, Deretic V. Unveiling the roles of autophagy in innate and adaptive immunity. Nat Rev Immunol 2007 7 : 767 777.
9. Levine B, Kroemer G. Autophagy in the pathogenesis of diseases. Cell 2008 132 : 27 42.
10. Watanabe I, Ichiki M, Shiratsuchi A, Nakanishi Y. TLR2-mediated survival of Staphylococcus aureus in macrophages: a novel bacterial strategy against host innate immunity. J Immunol 2007 178 : 4917 4925.
11. Hashimoto M, Tawaratsumida K, Kariya H, Kiyohara A, Suda Y, Krikae F, Kirikae T, Götz F. Not lipoteichoic acid but lipoproteins appear to be the dominant immunobiologically active compounds in Staphylococcus aureus. J Immunol 2006 177 : 3162 3169.
12. Jin MS, Kim SE, Heo JY, Lee ME, Kim HM, Paik S-G, Lee H, Lee J-O. Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell 2007 130 : 1071 1082.
13. Zähringer U, Lindner B, Inamura S, Heine H, Alexander C. TLR2 - promiscuous or specific? A critical re-evaluation of a receptor expressing apparent broad specificity. Immunology 2008 213 : 205 224.
14. Kurokawa K, Lee H, Roh K-B et al. The triacylated ATP binding cluster transporter substrate-binding lipoprotein of Staphylococcus aureus functions as a native ligand for the toll-like receptor 2. J Biol Chem 2009 284 : 8406 8411.
15. Schmaler M, Jann NJ, Ferracin F, Landolt LZ, Biswas L, Götz F, Landmann R. Lipoproteins in Staphylococcus aureus mediate inflammation by TLR2 and iron-dependent growth in vivo. J Immunol 2009 182 : 7110 7118.
16. Tawaratsumida K, Furuyashiki M, Katsumoto M, Fujimoto Y, Fukase K, Suda Y, Hashimoto M. Characterization of N-terminal structure of TLR2-activating lipoprotein in Staphylococcus aureus. J Biol Chem 2009 284 : 9147 9152.
17. Turner JD, Langley RS, Johnston KL et al. Wolbachia lipoprotein stimulates innate and adaptive immunity through toll-like receptors 2 and 6 (TLR2/6) to induce disease manifestations of filariasis. J Biol Chem 2009 284 : 22364 22378.
18. von Aulock S, Hartung T, Hermann C. Comment on "Not lipoteichoic acid but lipoproteins appear to be the dominant immunobiologically active compounds in Staphylococcus aureus". J Immunol 2007 178 : 2610.
19. Novick RP, Ross HF, Projan SJ, Kornblum J, Kreiswirth B, Moghazeh S. Synthesis of staphylococcal virulence factors is controlled by a regulatory RNA molecule. EMBO J 1993 12 : 3967 3975.
20. Tao L, LeBlanc DJ, Ferretti JJ. Novel streptococcal-integration shuttle vectors for gene cloning and inactivation. Gene 1992 120 : 105 110.
21. Shiratsuchi A, Nakanishi Y. Phosphatidylserine-mediated phagocytosis of anticancer drug-treated cells by macrophages. J Biochem 1999 26 : 1101 1106.
22. Takeuchi O, Hoshino K, Kawai T, Sanjo H, Takada H, Ogawa T, Takeda K, Akira S. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacteria cell wall components. Immunity 1999 11 : 443 451.
23. Chen PS Jr., Toribara TY, Warner H. Microdetermination of phosphorus. Anal Chem 1956 28 : 1756 1758.
24. Wolters PJ, Hildebrandt KM, Dickie JP, Anderson JS. Polymer length of teichuronic acid released from cell walls of Micrococcus luteus. J Bacteriol 1990 172 : 5154 5159.
25. Shiratsuchi A, Watanabe I, Takeuchi O, Akira S, Nakanishi Y. Inhibitory effect of Toll-like receptor 4 on fusion between phagosomes and endosomes/lysosomes in macrophages. J Immunol 2004 172 : 2039 2047.
26. Means TK, Wang S, Lien E, Yoshimura A, Golenbock DT, Fenton MJ. Toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. J Immunol 1999 163 : 3920 3927.
27. Ikeda Y, Adachi Y, Ishibashi K, Miura N, Ohno N. Activation of Toll-like receptor-mediated NF-κB by zymosan-derived water-soluble fraction: possible contribution of endotoxin-like substances. Immunopharmacol Immunotoxicol 2005 27 : 285 298.
28. Neuhaus FC, Baddiley J. A continuum of anionic charge: structures and functions of d-alanyl-teichoic acids in gram-positive bacteria. Microbiol Mol Biol Rev 2003 67 : 686 723.
29. Kurokawa K, Kaito C, Sekimizu K. Two-component signaling in the virulence of Staphylococcus aureus: a silkworm larvae-pathogenic agent infection model of virulence. Methods Enzymol 2007 422 : 233 244.
30. Herbert S, Bera A, Nerz C et al. Molecular basis of resistance to muramidase and cationic antimicrobial peptide activity of lysozyme in staphylococci. PLoS Pathog 2007 3 : e102.
31. Morath S, Stadelmaier A, Geyer A, Schmidt RR, Hartung T. Synthetic lipoteichoic acid from Staphylococcus aureus is a potent stimulus of cytokine release. J Exp Med 2002 195 : 1635 1640.
32. Kristian SA, Lauth X, Nizet V, Goetz F, Neumeister B, Peschel A, Landmann R. Alanylation of teichoic acids protects Staphylococcus aureus against Toll-like receptor 2-dependent host defense in a mouse tissue cage infection model. J Infect Dis 2003 188 : 414 423.
33. Chan KG, Mayer M, Davis EM, Halperin SA, Lin T-J, Lee SF. Role of d-alanylation of Streptococcus gordonii lipoteichoic acid in innate and adaptive immunity. Infect Immun 2007 75 : 3033 3042.
34. Weidenmaier C, Kokai-Kun JF, Kristian SA et al. Role of teichoic acids in Staphylococcus aureus nasal colonization, a major risk factor in nosocomial infections. Nat Med 2004 10 : 243 245.
35. Blander JM, Medzhitov R. Regulation of phagosome maturation by signals from toll-like receptors. Science 2004 304 : 1014 1018.
36. Blander JM, Medzhitov R. Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature 2006 440 : 808 812.
37. Apetoh L, Ghiringhelli F, Tesniere A et al. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med 2007 13 : 1050 1059.
38. Blander JM. Coupling toll-like receptor signaling with phagocytosis: potentiation of antigen presentation. Trends Immunol 2007 28 : 19 25.
39. Apetoh L, Ghiringhelli F, Tesniere A et al. The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy. Immunol Rev 2007 220 : 47 59.
40. Blander JM. Signalling and phagocytosis in the orchestration of host defense. Cell Microbiol 2007 9 : 290 299.
41. Apetoh L, Tesniere A, Ghiringhelli F, Kroemer G, Zitvogel L. Molecular interactions between dying tumor cells and the innate immune system determine the efficacy of conventional anticancer therapies. Cancer Res 2008 68 : 4026 4030.
42. Kaito C, Sekimizu K. Colony spreading in Staphylococcus aureus. J Bacteriol 2007 189 : 2553 2557.
43. Oku Y, Kurokawa K, Matsuo M, Yamada S, Lee B-L, Sekimizu K. Pleiotropic roles of polyglycerolphosphate synthase of lipoteichoic acid in growth of Staphylococcus aureus cells. J Bacteriol 2009 191 : 141 151.
44. Takahashi J, Komatsuzawa H, Yamada S et al. Molecular characterization of an atl null mutant of Staphylococcus aureus. Microbiol Immunol 2002 46 : 601 612.
45. Ichihashi N, Kurokawa K, Matsuo M, Kaito C, Sekimizu K. Inhibitory effects of basic or neutral phospholipid on acidic phospholipid-mediated dissociation of adenine nucleotide bound to DnaA protein, the initiator of chromosomal DNA replication. J Biol Chem 2003 278 : 28778 28786.